Julia Barnes-Weise, JD, CLP is the founder and Executive Director of the Global Healthcare Innovation Alliances Accelerator (GHIAA), a non-profit company that develops, promotes and consults on the use of agreement provisions, access planning and negotiation strategies to increase equitable access.
GHIAA’s MAPGuideⓇ platform is a tool for accessing and exploring analysis of global health agreements, particularly those that seek to ensure equitable access to medical products. It includes the Equitable Access Toolkit which is a Practical Guide to Access-Oriented Policies, Partnerships and Agreement Provisions.
Through GHIAA she has been a senior consultant to major funders of medical product development and other multinational organizations.
Barnes-Weise trained as a lawyer and worked for decades in the biopharma industry. She was previously a Director of Business Development at GSK and then worked as a business development consultant internationally for a number of biopharma companies.
Before founding GHIAA she was a visiting faculty member in the Duke University Sanford School of Public Policy and taught in the Access to Medicines seminar in the Duke School of Law.
Barnes-Weise is now is a non-profit executive, speaker, global health policy consultant, business development and negotiations advisor, and board member. She is a Certified Licensing Professional (CLP) with extensive experience negotiating licenses and alliance agreements.
Her education includes a Juris Doctor degree from the University of North Carolina, completion of a Notre Dame London Law Centre international trade law program, a BA from Ohio Wesleyan University and a management program at Duke University’s Fuqua Business School in International Marketing.
Barnes-Weise served on the board of the Licensing Executive Society and the Medical University of South Carolina’s Foundation for Research and Development. She has served on a number of task forces, including at Harvard Medical School and UC Berkeley’s Innovative Genomics Institute. Her publications are on topics related to global public health security and equitable access to medicines.
